Anna Protopapas

(Ms. Anna Protopapas)

Currently holds positions in Dicerna Pharmaceuticals Inc and Mersana Therapeutics Inc

Positions

Position Company Period
Independent Director Dicerna Pharmaceuticals Inc Jan. 23, 2019 -
President, Chief Executive Officer, Director Mersana Therapeutics Inc March 1, 2015 -
Independent Director Bioverativ Inc Feb. 1, 2017 - March 8, 2018
Independent Director ARIAD Pharmaceuticals Inc April 28, 2015 - Feb. 16, 2017
Anna Protopapas's trades of Nuvalent Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-17 2025-01-16
PS Planned sale
8,637 -4.9%
0.58
USD 5,009 		8,637 -4.9% 0.58 USD 5,009
2025-01-16 2025-01-15
PS Planned sale
6,191 -3.8%
0.63
USD 3,900 		6,191 -3.8% 0.63 USD 3,900
2025-01-15 2025-01-14
PS Planned sale
11,534 -7.4%
0.66
USD 7,612 		11,534 -7.4% 0.66 USD 7,612
2024-01-17 2024-01-16
PS Planned sale
29,399 -19.0%
2.71
USD 79,671 		29,399 -19.0% 2.71 USD 79,671
2023-12-20 2023-12-18
US Nuvalent Inc (NUVL)
S Sale
5,000 -100.0%
75.67
USD 378,350 		5,000 -100.0% 75.67 USD 378,350
2023-01-18 2023-01-17
S Sale
17,346 -26.3%
5.74
USD 99,566 		17,346 -26.3% 5.74 USD 99,566
// ... existing code ... // ... rest of the file ...